We are live on ! Find out more
ENTA icon

Enanta Pharmaceuticals
ENTA

42 hedge funds and large institutions have $60.9M invested in Enanta Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 42 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
42
Holders Change
+42
Holders Change %
–
% of All Funds
1.37%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
42
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$237K +$261K +13,398 New
NSEDCP
27
NJ State Employees Deferred Compensation Plan
New Jersey
$221K +$244K +12,500 New
BIM
28
BlackRock Investment Management
Delaware
$161K +$177K +9,088 New
TRCT
29
Tower Research Capital (TRC)
New York
$122K +$134K +6,895 New
California State Teachers Retirement System (CalSTRS)
30
California State Teachers Retirement System (CalSTRS)
California
$112K +$124K +6,343 New
Bank of America
31
Bank of America
North Carolina
$86K +$95.1K +4,875 New
TA
32
Teachers Advisors
New York
$81K +$89.6K +4,594 New
SO
33
STRS Ohio
Ohio
$30K +$33.1K +1,700 New
AllianceBernstein
34
AllianceBernstein
Tennessee
$24K +$26.4K +1,352 New
U
35
UBS
Switzerland
$20K +$21.8K +1,116 New
NFA
36
Nationwide Fund Advisors
Ohio
$20K +$22.3K +1,142 New
SSG
37
Summit Securities Group
New York
$18K +$19.5K +1,000 New
GT
38
Glenmede Trust
Pennsylvania
$17K +$19.5K +1,000 New
GPGA
39
Grandeur Peak Global Advisors
Utah
$5K +$5.85K +300 New
Ameriprise
40
Ameriprise
Minnesota
$4K +$4.43K +227 New
Manulife (Manufacturers Life Insurance)
41
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2K +$2.5K +128 New
Citigroup
42
Citigroup
New York
– +$97 +5 New
1
2

ENTA Hedge Fund Activity: Q2 2013 in Review

42 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Enanta Pharmaceuticals (ENTA) for Q2 2013, worth a combined $60.9M.

Buyers outnumbered sellers: 42 funds opened new ENTA positions and 0 closed out — a net gain of 42 holders — while 0 added to existing stakes and 0 trimmed.

  • 42 institutional investors held Enanta Pharmaceuticals (ENTA) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $60.9M of Enanta Pharmaceuticals stock for Q2 2013.
  • 42 funds opened new Enanta Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +42 holders.

Based on aggregated 13F filings for Q2 2013.